glp 1 direct to consumer GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors From 'companion foods' to 'Nature's
Description
Decision-makers in charge of employee health plans agree that coverage for GLP-1s could keep employees healthier

Because Noom withholds the rest of its pharmacy list, we cannot verify the disciplinary history of the pharmacies that may fill future refills

Davies M, Pieber TR, Hartoft-Nielsen ML, et al

Source: Novo Investor Day 2022 Estimating the costs associated with diseases are inherently imprecise and noisy due to difficulties in normalising the difference between individual circumstances and lifestyles, but for the sake of providing ball-park figures, some studies have found that excess medical spending on obesity for adults is around 260 billion USD or around 1800 USD excess per person in 2019

Tirzepatide for obesity treatment and diabetes prevention